Japan’s Eisai still seeking accelerated U.S. review of Alzheimer’s drug
Eisai Co. on Friday said it still plans to seek an accelerated U.S. approval pathway for ...
Read moreDetails
Tag: accelerated
Eisai Co. on Friday said it still plans to seek an accelerated U.S. approval pathway for ...
Read moreDetails